Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
176.76
-2.33 (-1.30%)
At close: Feb 3, 2026, 4:00 PM EST
177.78
+1.02 (0.58%)
Pre-market: Feb 4, 2026, 7:17 AM EST

Biogen Market Cap

Biogen has a market cap or net worth of $25.93 billion as of February 4, 2026. Its market cap has increased by 26.00% in one year.

Market Cap
25.93B
Enterprise Value
28.56B
1-Year Change
26.00%
Ranking
Category
Stock Price
$176.76

Market Cap Chart

Since December 1, 1998, Biogen's market cap has increased from $617.50M to $25.93B, an increase of 4,099.37%. That is a compound annual growth rate of 14.73%.

History

DateMarket Cap% Change
Feb 2, 202626.27B1.76%
Dec 31, 202525.82B15.86%
Dec 31, 202422.28B-40.57%
Dec 29, 202337.50B-5.97%
Dec 30, 202239.88B13.15%
Dec 31, 202135.24B-6.47%
Dec 31, 202037.68B-29.63%
Dec 31, 201953.54B-11.69%
Dec 31, 201860.63B-10.00%
Dec 29, 201767.37B9.19%
Dec 30, 201661.70B-9.65%
Dec 31, 201568.29B-14.82%
Dec 31, 201480.16B21.39%
Dec 31, 201366.04B90.69%
Dec 31, 201234.63B29.54%
Dec 30, 201126.73B67.31%
Dec 31, 201015.98B3.27%
Dec 31, 200915.47B11.34%
Dec 31, 200813.90B-16.78%
Dec 31, 200716.70B0.70%
Dec 29, 200616.58B7.90%
Dec 30, 200515.37B-30.83%
Dec 31, 200422.22B288.89%
Dec 31, 20035.71B12.55%
Dec 31, 20025.08B-51.71%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
AstraZeneca293.45B
Novartis AG289.31B
Merck & Co.287.52B
Novo Nordisk258.45B
Amgen182.32B
Gilead Sciences177.76B
Pfizer146.52B
Sanofi115.79B
Market Cap Rankings